Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126251551 | 12625155 | 1 | I | 20160725 | 20160805 | 20160805 | EXP | US-PAR PHARMACEUTICAL COMPANIES-2016SCPR015692 | PAR | OWUSU-AGYEMANG P., CATA J.P., FOURNIER K.F., ZAVALA A.M., SOLIZ J., HERNANDEZ M., HAYES-JORDAN A., GOTTUMUKKALA V.. EVALUATING THE IMPACT OF TOTAL INTRAVENOUS ANESTHESIA ON THE CLINICAL OUTCOMES AND PERIOPERATIVE NLR AND PLR PROFILES OF PATIENTS UNDERGOING CYTOREDUCTIVE SURGERY WITH HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY. ANNALS OF SURGICAL ONCOLOGY. 2016;23(8):2419-2429 | 0.00 | Y | 0.00000 | 20160805 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126251551 | 12625155 | 1 | PS | KETALAR | KETAMINE HYDROCHLORIDE | 1 | 10 MG /HR | U | U | 16812 | 10 | MG | INJECTION | ||||||
| 126251551 | 12625155 | 2 | SS | KETALAR | KETAMINE HYDROCHLORIDE | 1 | 10 MG, UNK | U | U | 16812 | 10 | MG | INJECTION | ||||||
| 126251551 | 12625155 | 3 | SS | TRAMADOL. | TRAMADOL | 1 | Unknown | 300 MG, UNKNOWN | U | U | 0 | 300 | MG | ||||||
| 126251551 | 12625155 | 4 | SS | DEXMEDETOMIDINE HYDROCHLORIDE. | DEXMEDETOMIDINE HYDROCHLORIDE | 1 | 0.3 MCG/KG /HR | U | U | 0 | INJECTION | ||||||||
| 126251551 | 12625155 | 5 | SS | DEXMEDETOMIDINE HYDROCHLORIDE. | DEXMEDETOMIDINE HYDROCHLORIDE | 1 | U | U | 0 | INJECTION | |||||||||
| 126251551 | 12625155 | 6 | SS | PROPOFOL. | PROPOFOL | 1 | 30-50 MCG/KG/MIN, UNKNOWN | 0 | INJECTION | ||||||||||
| 126251551 | 12625155 | 7 | SS | PROPOFOL. | PROPOFOL | 1 | 50-150 MCG/KG/MIN, UNKNOWN | 0 | INJECTION | ||||||||||
| 126251551 | 12625155 | 8 | SS | PROPOFOL. | PROPOFOL | 1 | 0.2-0.5 MG/KG, UNKNOWN | 0 | INJECTION | ||||||||||
| 126251551 | 12625155 | 9 | SS | LIDOCAINE. | LIDOCAINE | 1 | 2 MG/MIN, UNKNOWN | U | U | 0 | INJECTION | ||||||||
| 126251551 | 12625155 | 10 | SS | LIDOCAINE. | LIDOCAINE | 1 | 1.5 MG/KG, UNKNOWN | U | U | 0 | 1.5 | MG/KG | INJECTION | ||||||
| 126251551 | 12625155 | 11 | SS | CELECOXIB. | CELECOXIB | 1 | Unknown | 300-400 MG, UNKNOWN | U | U | 0 | ||||||||
| 126251551 | 12625155 | 12 | SS | PREGABALIN. | PREGABALIN | 1 | Unknown | 75-150, UNKNOWN | U | U | 0 | ||||||||
| 126251551 | 12625155 | 13 | C | CISATRACURIUM. | CISATRACURIUM | 1 | Unknown | UNK, UNKNOWN | 0 | ||||||||||
| 126251551 | 12625155 | 14 | C | ROCURONIUM | ROCURONIUM BROMIDE | 1 | Unknown | UNK, UNKNOWN | 0 | ||||||||||
| 126251551 | 12625155 | 15 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Intravenous (not otherwise specified) | 10 MG, UNKNOWN | 0 | 10 | MG | INJECTION | |||||||
| 126251551 | 12625155 | 16 | C | LIDOCAINE. | LIDOCAINE | 1 | Epidural | 3-10 ML, UNKNOWN | 0 | ||||||||||
| 126251551 | 12625155 | 17 | C | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE | BUPIVACAINE HYDROCHLORIDEEPINEPHRINE BITARTRATE | 1 | Epidural | BUPIVACAINE 0.075 % WITH EPINEPHRINE 1.5 LG/ML, UNKNOWN | 0 | INJECTION | |||||||||
| 126251551 | 12625155 | 18 | C | HYDROMORPHONE | HYDROMORPHONE | 1 | Epidural | 0.6-1 MG, BOLUS | 0 | INJECTION | |||||||||
| 126251551 | 12625155 | 19 | C | HYDROMORPHONE | HYDROMORPHONE | 1 | Epidural | 5 MCG/ML, UNKNOWN | 0 | INJECTION | |||||||||
| 126251551 | 12625155 | 20 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Intravenous (not otherwise specified) | UNK UNK, UNKNOWN | 0 | INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126251551 | 12625155 | 1 | Induction of anaesthesia |
| 126251551 | 12625155 | 2 | Maintenance of anaesthesia |
| 126251551 | 12625155 | 3 | Antiinflammatory therapy |
| 126251551 | 12625155 | 4 | Induction of anaesthesia |
| 126251551 | 12625155 | 5 | Maintenance of anaesthesia |
| 126251551 | 12625155 | 6 | Induction of anaesthesia |
| 126251551 | 12625155 | 7 | Maintenance of anaesthesia |
| 126251551 | 12625155 | 9 | Induction of anaesthesia |
| 126251551 | 12625155 | 10 | Maintenance of anaesthesia |
| 126251551 | 12625155 | 11 | Antiinflammatory therapy |
| 126251551 | 12625155 | 12 | Antiinflammatory therapy |
| 126251551 | 12625155 | 13 | Muscle relaxant therapy |
| 126251551 | 12625155 | 14 | Muscle relaxant therapy |
| 126251551 | 12625155 | 15 | Product used for unknown indication |
| 126251551 | 12625155 | 16 | Product used for unknown indication |
| 126251551 | 12625155 | 17 | Analgesic therapy |
| 126251551 | 12625155 | 18 | Analgesic therapy |
| 126251551 | 12625155 | 20 | Analgesic therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126251551 | 12625155 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126251551 | 12625155 | Anastomotic leak | |
| 126251551 | 12625155 | Arrhythmia | |
| 126251551 | 12625155 | Blood disorder | |
| 126251551 | 12625155 | Deep vein thrombosis | |
| 126251551 | 12625155 | Delirium | |
| 126251551 | 12625155 | Diarrhoea | |
| 126251551 | 12625155 | Enterocutaneous fistula | |
| 126251551 | 12625155 | Ileus | |
| 126251551 | 12625155 | Multi-organ disorder | |
| 126251551 | 12625155 | Pneumonia | |
| 126251551 | 12625155 | Pulmonary embolism | |
| 126251551 | 12625155 | Pulmonary oedema | |
| 126251551 | 12625155 | Renal disorder | |
| 126251551 | 12625155 | Respiratory failure | |
| 126251551 | 12625155 | Sepsis | |
| 126251551 | 12625155 | Septic shock | |
| 126251551 | 12625155 | Urinary tract infection | |
| 126251551 | 12625155 | Vomiting | |
| 126251551 | 12625155 | Wound infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |